Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer
Year: 2011
Type: article
Study design: Observational Study
Abstract: AIMS: Despite continual efforts to develop prognostic and predictive models of colorectal cancer by using clinicopathological and genetic parameters, a clinical test that can discriminate between patients with good or poor outcome after treatment has not been established. Thus, the authors aim to uncover subtypes of colorectal cancer that have distinct biological characteristics associated with prognosis and identify potential biomarkers that best reflect the biological and clinical characteristics of subtypes. METHODS: Unsupervised hierarchical clustering analysis was applied to gene expression data from 177 patients with colorectal cancer to determine a prognostic gene expression signature. Validation of the signature was sought in two independent patient groups. The association between the signature and prognosis of patients was assessed by Kaplan-Meier plots, log-rank tests and the Cox model. RESULTS: The authors identified a gene signature that was associated with overall survival and disease-free survival in 177 patients and validated in two independent cohorts of 213 patients. In multivariate analysis, the signature was an independent risk factor (HR 3.08; 95% CI 1.33 to 7.14; p=0.008 for overall survival). Subset analysis of patients with AJCC (American Joint Committee on Cancer) stage III cancer revealed that the signature can also identify the patients who have better outcome with adjuvant chemotherapy (CTX). Adjuvant chemotherapy significantly affected disease-free survival in patients in subtype B (3-year rate, 71.2% (CTX) vs 41.9% (no CTX); p=0.004). However, such benefit of adjuvant chemotherapy was not significant for patients in subtype A. CONCLUSION: The gene signature is an independent predictor of response to chemotherapy and clinical outcome in patients with colorectal cancer.
Source: Gut
Institutions: The University of Texas MD Anderson Cancer Center, Korea University, Korea University Medical Center, Yonsei University, Yonsei University Health System, Jeonbuk National University Hospital, Jeonbuk National University, Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Vanderbilt University, Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: EMT regulation in gastrointestinal epithelial cells, SPORE in GI Cancer, Center for Clinical and Translational Sciences (CCTS), Systems Approach to the Biological Basis of Colon Cancer Metastases, CELLULAR AND MOLECULAR MECHANISMS OF GASTROINTESTINAL CANCERS, Moffitt Cancer Center Support Grant, Cancer Center Support Grant, Cancer Center Support Grant
OpenAlex ID: W2113088269
